Home » MD Anderson Inks Deal to Acquire Elekta’s Linear Accelerators
MD Anderson Inks Deal to Acquire Elekta’s Linear Accelerators
The University of Texas MD Anderson Cancer Center has entered an agreement to acquire Elekta’s Infinity linear accelerators, brachytherapy afterloaders and software and service for an undisclosed sum.
The deal also includes Elekta’s beam-shaping product — the Agility 160-leaf multi-leaf collimator — as well as four high-dose-rate branchytherapy afterloaders and Oncentra Brachy treatment planning.
The order will be finalized during Elekta’s fourth quarter. — Anisa Jibrell
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May